EXPLEOSOL Q4 FY26 Guidance vs Delivery (EXPLEOSOL Management Mirror)

Did EXPLEOSOL's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • EXPLEOSOL Financials
  • EXPLEOSOL Shareholding Pattern
  • EXPLEOSOL Earnings Documents
  • EXPLEOSOL Announcements
  • EXPLEOSOL Corporate Actions
  • EXPLEOSOL Bulk, Block & Insider Deals
  • EXPLEOSOL Delivery Data
  • EXPLEOSOL Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Expleo Solutions Ltd (EXPLEOSOL) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue Growth

Management now targets sustainable double-digit revenue growth for the upcoming year (Mar'26 Qtr), an upgrade from the prior high single-digit guidance for the current fiscal year (Sep'25 Qtr), which was itself a reaffirmation of directional single-digit growth projected initially (Mar'25 Qtr), reflecting accelerating momentum despite AI-driven ticket size pressures. [Status: Upgraded]

5 more themes on the ELITE plan.

  • EXPLEOSOL Q4FY26 Concall Summary
  • EXPLEOSOL Q4FY26 Concall Transcript
  • EXPLEOSOL Q2FY26 Management Mirror (Sep-2025 Qtr)